Year in Review, RealTime Software Solutions

Year in Review, RealTime Software Solutions

As we bid farewell to 2023, we take a moment to reflect on the incredible journey we’ve had at RealTime Software Solutions. This year has been marked by innovation, growth, and a steadfast commitment to advancing clinical trial management. Here’s a look at our year in review. Global Impact RealTime continues to make an impact … Read more

Overcoming the Barriers and Risks Related to N of 1 Trials

Complion N of 1 Trials

There has been a sharp increase in the demand for n of 1 trials. Many institutions are vying to become the dominant leader in this space because of the numerous benefits. However, significant challenges are preventing scaling these trial types, primarily regulatory compliance. Leading research institutions rely on Complion eRegulatory to help overcome these barriers. … Read more

RealTime Software Solutions Welcomes Stephen Johnson as CEO; Rick Greenfield Assumes Role of Founder & President

SAN ANTONIO, TX, Aug. 8, 2022  – RealTime Software Solutions, LLC, a leader in the clinical trials software solutions industry, is pleased to announce that Stephen Johnson has been named CEO. Rick Greenfield, BBA-IS, will transition into the role of Founder & President and remain highly engaged in the company as the leader of the … Read more

The Role of IRBs in Clinical Research: A Quick Guide

Institutional review boards (IRBs) are ethics review committees that ensure human research subjects’ rights are protected, as well as the rights of the patients who ultimately benefit from the research. Operating under US federal regulations, state laws, and institutional policies, the IRB has the authority to approve, require modification to, and disapprove research. IRBs are an important part of regulatory efforts and their approval is required for all human research. Here’s a quick overview of IRBs and the expectations for working with them.

SIP integration developed for KU Cancer Center

SIP integration

Clinical researchers are looking for ways to reduce the operational challenges of clinical trials which can often occur by working with multiple sponsors. Some of these challenges include working with individual sponsor portals, using disparate processes and numerous platforms — each with a unique login credential – which can all lead to increased probability for error and placing patient safety in jeopardy.

As a result, a Shared Investigator Platform (SIP) integration, which can streamline the interaction with multiple sponsors, has become a high priority for many sites.